Austin, TX 的 前列腺癌 臨床試驗
15 項針對 前列腺癌 的研究正在 Austin（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
招募中1/2 期
- New Experimental Therapeutics - NEXT Oncology, Austin
Impact of Fluciclovine (18F) PET (Positron Emission Tomography) on the Management of Prostate Cancer Following Negative or Equivocal PSMA (Prostate-Specific Membrane Antigen) PET Imaging at the Time of Biochemical Recurrence
招募中4 期
- Urology Austin, Austin
Barrigel® PPRT (Post-Prostatectomy Radiation Therapy) Trial
招募中
- Urology Austin, Austin
Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer
招募中1/2 期
- NEXT Oncology, Austin
A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)
招募中3 期
- Texas Oncology - Central/South Texas ( Site 8003), Austin
Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
招募中3 期
- Urology Austin, Lakeway · 距離 16 英里
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
招募中3 期
- Research Site, Austin
- Research Site, Austin
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
招募中3 期
- Urology Austin, PLLC - Research Department, Austin
PSMA PET Combined With MRI for the Detection of PCa
招募中3 期歡迎健康志工
- Urology Austin, Austin
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
招募中1 期
- NEXT Oncology Austin, Austin
This is a Phase 1 Trial of ZM008, an Anti-LLT1 Antibody, Used as Single Agent Followed by Combination Treatment With Toripalimab in Patients With Advanced Solid Tumors
招募中1 期
- NEXT Oncology, Austin, TX 78758
cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
招募中觀察性研究歡迎健康志工
- Elligo Health Research, Inc., Austin
Sample Collection for Ongoing Research and Product Evaluation Study
招募中觀察性研究
- Natera, Inc., Austin
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 135, Austin
A Phase 1 Study of XL309 (ISM3091) Alone and in Combination in Participants With Advanced Solid Tumors
招募中1 期
- Exelixis Clinical Site #4, Austin
其他城市的 前列腺癌 試驗
- New York City, NY103 項研究
- Houston, TX76 項研究
- Los Angeles, CA61 項研究
- Boston, MA59 項研究
- St. Louis, MO46 項研究
- Chicago, IL45 項研究
- San Francisco, CA45 項研究
- Philadelphia, PA44 項研究
- Baltimore, MD43 項研究
- Nashville, TN42 項研究
- Seattle, WA42 項研究
- Washington, DC38 項研究
Austin 的其他研究
- 非小細胞肺癌30 項研究
- 癌症（所有類型）20 項研究
- 肥胖症20 項研究
- 轉移性癌症19 項研究
- 大腸直腸癌19 項研究
- 心臟衰竭18 項研究
- 乳癌18 項研究
- 過重18 項研究
- 卵巢癌17 項研究
- 子宮內膜癌15 項研究
- 憂鬱症14 項研究
- 三陰性乳癌13 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月5日。各研究自行設定資格標準；由研究團隊決定參與者資格。